Countries Around the World Seek to Import Israeli Cannabis Products but Cannot Due to Israel Government Bureaucracy Preventing Approval: “The Israeli Export Window is Closing.”
ISRAEL: Tefen, a new Israeli licensed medical-grade cannabis producer has recently concluded two deals valued at approximately $23 million to supply 14 tons of medical-grade cannabis to a large Israeli processor and distributor over the next three years.
The growing facility will be on a 20 dunam (4.94 acres) farm in central Israel which can produce up to 20 tons of cannabis per year. The publicly traded company is in the process of constructing an automated cultivation facility in central Israel and will be ready to also sell internationally if the Israeli government approves the export of cannabis.
Tefen’s management, development team and advisors have proven professional knowledge in the international cannabis and drug development industries, including cannabis growing facilities in South America, Canada and Israel.
Based on the U.S. market for medicinal cannabis, it is estimated that 1.25% – 2% of the population will eventually consume medicinal cannabis. These percentages are expected to be similar in all international markets that legalize medicinal cannabis.